Maeda M, Sugimura M, Kobayashi T, Terao T, Kawashima Y, Sabashi Y, Nakajima K, Uchida T, Nagano T, Kohda M
Department of Obstetrics and Gynecology, Hamamatsu University School of Medicine.
Nihon Sanka Fujinka Gakkai Zasshi. 1989 Dec;41(12):1921-8.
The remission rate of choriocarcinoma has greatly improved since the introduction of effective multiagent chemotherapy combined with aggressive surgical therapy and radiotherapy. In addition to these, the registration and follow-up of gestational trophoblastic disease (GTD) also has been playing an important role in the early detection and treatment of choriocarcinoma following hydatidiform mole. The system for the registration and follow-up of GTD was started in 1977 in Shizuoka Prefecture. In the present series, the results obtained with this registration and follow-up system from 1977 to 1988 in Shizuoka Prefecture were reviewed and analysed. 1) One thousand, nine hundred and twenty-five cases of hydatidiform mole, 68 cases of invasive mole, 70 cases of persistent trophoblastic disease and 48 cases of choriocarcinoma were registered in 12 years. The overall registration rate was 97.4%. 2) The number of cases of hydatidiform mole registered has decreased from about 180 cases to about 140 cases per year, probably due to the decreasing birth rate. 3) The number of cases of choriocarcinoma registered has recently been decreasing significantly and the number of cases of registered invasive mole and persistent trophoblastic disease has decreased slightly. 4) Antecedent pregnancy with choriocarcinoma including clinical choriocarcinoma has been changing from "post-molar" to "post-term" in the past 12 years. The prognosis of the patient with choriocarcinoma following hydatidiform mole has improved by the early detection and treatment since the introduction of the registration and follow-up system. More attention should be paid to choriocarcinoma following term gestation not yet included in the registration and follow-up system to facilitate early detection and treatment.
自引入有效的多药联合化疗并结合积极的手术治疗和放疗以来,绒毛膜癌的缓解率有了显著提高。除此之外,妊娠滋养细胞疾病(GTD)的登记和随访在葡萄胎后绒毛膜癌的早期发现和治疗中也发挥着重要作用。GTD登记和随访系统于1977年在静冈县启动。在本系列研究中,回顾并分析了1977年至1988年在静冈县使用该登记和随访系统所获得的结果。1)12年间共登记了1925例葡萄胎、68例侵蚀性葡萄胎、70例持续性滋养细胞疾病和48例绒毛膜癌。总体登记率为97.4%。2)每年登记的葡萄胎病例数已从约180例降至约140例,这可能是由于出生率下降所致。3)最近登记的绒毛膜癌病例数显著减少,登记的侵蚀性葡萄胎和持续性滋养细胞疾病病例数略有下降。4)在过去12年中,包括临床绒毛膜癌在内的绒毛膜癌的前次妊娠已从“葡萄胎后”转变为“足月产后”。自引入登记和随访系统以来,葡萄胎后绒毛膜癌患者的预后因早期发现和治疗而得到改善。应更加关注尚未纳入登记和随访系统的足月妊娠后绒毛膜癌,以便于早期发现和治疗。